Semaglutide is a long-acting glucagon-like peptide-1 (GLP-1) receptor agonist commonly studied for its effects on glucose metabolism, appetite regulation, and body weight. Research has shown its potential to promote insulin secretion, reduce gastric emptying, and decrease appetite, making it a popular compound in studies focused on metabolic health, obesity, and type 2 diabetes.

Products are provided in lyophilized powder form and require reconstitution prior to use in research or laboratory testing.

For research use only. Not for human or animal consumption.